Tumor Necrosis Factor Receptor Superfamily Member 19 (TNFRSF19) Regulates Differentiation Fate of Human Mesenchymal (Stromal) Stem Cells through Canonical Wnt Signaling and C/EBP*

Mechanisms controlling human multipotent mesenchymal (stromal) stem cell (hMSC) differentiation into osteoblasts or adipocytes are poorly understood. We have previously demonstrated that Wnt signaling in hMSC enhanced osteoblast differentiation and inhibited adipogenesis by comparing two hMSC cell lines overexpressing mutated forms of the Wnt co-receptor LRP5: T253I (hMSC-LRP5T253) and T244M (hMSC-LRP5T244) conducting high and low level of Wnt signaling, respectively. To explore the underlying molecular mechanisms, we compared gene expression profiles of hMSC-LRP5T253 and hMSC-LRP5T244 treated with Wnt3a using whole genome expression microarrays and found that TNFRSF19 is differentially up-regulated between the two cells lines. Bioinformatic analysis and dual luciferase assay of its promoter revealed that TNFRSF19 transcript 2 (TNFRSF19.2) is a target of canonical Wnt signaling. Knocking down TNFRSF19 in hMSC-LRP5T253 cells decreased Wnt3a-induced osteoblast differentiation marker alkaline phosphate activity and its overexpression in hMSC-LRP5T244 cells increased alkaline phosphate activity. In addition, TNFRSF19 was negatively regulated by adipogenic transcription factor CCAAT/enhancer-binding proteins (C/EBP). Knocking down TNFRSF19 in hMSC-LRP5T253 cells or its overexpression in hMSC-LRP5T244 cells significantly increased or decreased adipogenesis, respectively. In conclusion, we revealed a novel function of TNFRSF19 as a factor mediating differentiation signals that determine the hMSC differentiating fate into osteoblasts or adipocytes.

[1]  Minrong Ai,et al.  Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling , 2005, Molecular and Cellular Biology.

[2]  J. Latham,et al.  Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins* , 2005, Journal of Biological Chemistry.

[3]  Scott Saunders,et al.  Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Jens Bollerslev,et al.  Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. , 2003, American journal of human genetics.

[5]  L. Mosekilde,et al.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis , 2004, Biogerontology.

[6]  J. Gimble,et al.  Playing with bone and fat , 2006, Journal of cellular biochemistry.

[7]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[8]  N. Copeland,et al.  TROY, a Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily, Exhibits a Homology with Edar and Is Expressed in Embryonic Skin and Hair Follicles* , 2000, The Journal of Biological Chemistry.

[9]  I. Thesleff,et al.  Ectodysplasin, Edar and TNFRSF19 are expressed in complementary and overlapping patterns during mouse embryogenesis. , 2003, Gene expression patterns : GEP.

[10]  Yoichi Kato,et al.  LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.

[11]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[12]  Minrong Ai,et al.  Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. , 2005, American journal of human genetics.

[13]  Hans Clevers,et al.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.

[14]  W. Dynan.  Promoters for housekeeping genes , 1986 .

[15]  D. Reid,et al.  Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. , 2002, Human molecular genetics.

[16]  A TNF Receptor Family Member, TROY, Is a Coreceptor with Nogo Receptor in Mediating the Inhibitory Activity of Myelin Inhibitors , 2005, Neuron.

[17]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[18]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[19]  W. Han,et al.  An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression , 2004, Journal of Cell Science.

[20]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[21]  Jie J. Zheng,et al.  The LRP5 High-Bone-Mass G171V Mutation Disrupts LRP5 Interaction with Mesd , 2004, Molecular and Cellular Biology.

[22]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[23]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[24]  G. Karsenty,et al.  In vivo analysis of Wnt signaling in bone. , 2007, Endocrinology.

[25]  C. Thompson,et al.  Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. , 1998, Genes & development.

[26]  P. Marie,et al.  PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading , 2006, PPAR research.

[27]  Jennifer J Westendorf,et al.  Lymphoid Enhancer Factor-1 and β-Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter* , 2003, The Journal of Biological Chemistry.

[28]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[29]  T. Kitamura,et al.  Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. , 2003, Brain research. Developmental brain research.

[30]  Mark L. Johnson,et al.  Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.

[31]  Mauricio González,et al.  Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation , 2004, Journal of cellular biochemistry.

[32]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[33]  Michael B. Yaffe,et al.  TAZ: A β-Catenin-like Molecule that Regulates Mesenchymal Stem Cell Differentiation , 2006 .

[34]  S. Mandrup,et al.  Patients With High Bone Mass Phenotype Exhibit Enhanced Osteoblast Differentiation and Inhibition of Adipogenesis of Human Mesenchymal Stem Cells , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  D. Reid,et al.  Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture , 2004, Osteoporosis International.

[36]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[37]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[38]  K. Tamada,et al.  Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily. , 1999, Genomics.

[39]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[40]  Xi He,et al.  LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST* , 2006, Journal of Biological Chemistry.

[41]  John M. McCoy,et al.  TAJ/TROY, an Orphan TNF Receptor Family Member, Binds Nogo-66 Receptor 1 and Regulates Axonal Regeneration , 2005, Neuron.

[42]  M. Eby,et al.  TAJ, a Novel Member of the Tumor Necrosis Factor Receptor Family, Activates the c-Jun N-terminal Kinase Pathway and Mediates Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.

[43]  R. Baron.  Wnt signaling, LRP5 and gut serotonin: Have we been targeting the right pathway for the wrong reasons? , 2009 .

[44]  M. Devoto,et al.  Association Analysis of Bone Mineral Density and Single Nucleotide Polymorphisms in Two Candidate Genes on Chromosome 1p36 , 2003, Calcified Tissue International.

[45]  M. Karperien,et al.  Downregulation of Wnt Signaling by Increased Expression of Dickkopf‐1 and ‐2 is a Prerequisite for Late‐Stage Osteoblast Differentiation of KS483 Cells , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  T. Spector,et al.  Bone structural effects of variation in the TNFRSF1B gene encoding the tumor necrosis factor receptor 2 , 2008, Osteoporosis International.

[47]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[48]  N. Perrimon,et al.  The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.

[49]  P. Barker,et al.  Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development. , 2008, Human molecular genetics.

[50]  Michael T. McManus,et al.  Gene silencing using micro-RNA designed hairpins. , 2002, RNA.

[51]  H. Sul,et al.  Understanding adipocyte differentiation. , 1998, Physiological reviews.

[52]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[53]  Hui Shen,et al.  Epistatic Interactions between Genomic Regions Containing the COL1A1 Gene and Genes Regulating Osteoclast Differentiation may Influence Femoral Neck Bone Mineral Density , 2007, Annals of human genetics.